Anti-Cathepsin L [4C11]
Invented at A*STAR Accelerate Technologies Pte Ltd
- Datasheet
- References (0)
- Inventor Info
Info
Catalogue Number | 152642 |
Applications | IF WB |
Antigen/Gene or Protein Targets | Cathepsin L, HCL |
Reactivity | Human |
Relevance | Cathepsin L is expressed in most cells but in a higher level in cancerous cells. Normal levels of cathepsin L is involved in the regulation of epithelial cell proliferation and differentiation in the skin. It is recognized that many cancer cells secrete cathepsin L to degrade the components of extracellular matrices and basement membranes. This promotes tumor invasion and metastasis. The pro-form of cathepsin L exists as a molecular size of 50kDa. The pro-form could be degraded and secreted out as two smaller forms of cathepsin L. These smaller forms are known as the mature forms. The pro-forms and mature forms are secreted out of the healthy cells. However, there is a significant increase in levels of pro-forms that are secreted out of the cancerous cells. Monoclonal antibodies generated against pro-form of cathepsin L would be useful for diagnostic purposes. |
Host | Mouse |
Immunogen | GST-HCL fusion protein |
Positive Control | Human brain cell lysates, U-138MG cell line |
Subclass | IgM |
Myeloma Used | Sp2/0-Ag14 |
Research Area | Adhesion, Cancer, Cell Signaling & Signal Transduction, Neurobiology, Protein Degradation |
References
There are 0 reference entries for this reagent.
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference
References: 0 entry
There is no reference for this reagent yet, feel free to use the button below to suggest one.
Add a reference